Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-24

Clinical Trial Update: Study of Human Bone Marrow Mesenchymal Stem Cells in APAP [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating human bone marrow mesenchymal stem cells for autoimmune pulmonary alveolar proteinosis is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Bone Marrow Mesenchymal Stem Cells (mesenchymal stem cells)

Snippet

Sponsor: Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd. | Conditions: Autoimmune Pulmonary Alveolar Proteinosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING